Bill of Health

AUGUST 29, 2022

On October 8, 2020, Moderna, the maker of one of the first mRNA-based vaccines for COVID-19 and the recipient of billions of dollars of U.S. As a result, it publicly promised that “ while the pandemic continues, Moderna will not enforce our COVID-19 related patents against those making vaccines intended to combat the pandemic.”

COVID-19 Vaccine 362

COVID-19 Vaccine COVID-19 Licensing Governance 362

Health Populi

JULY 9, 2020

Combine these new life-flows with conflicting information about the nature, severity, and life-span of COVID-19: From three levels of government leaders: The President and the Executive Branch at the Federal Level, Governors of States, and Mayors of cities; Public health agencies, especially the U.S. Health citizens in the U.S.

US Department of Health and Human Services 124

US Department of Health and Human Services COVID-19 Doctors Hospitals 124

Health Populi

JUNE 30, 2020

say the future of America is a significant source of stress, as discussed in Stress in the Time of COVID-19, Volume Two , a report covering a poll of U.S. residents through the lens of health consumers and, especially this year and in this study, health citizens. adults age 19 and over between May 21 and June 3, 2020.

COVID-19 83

COVID-19 Governance World Health Health Outcomes 83

Health Populi

JULY 28, 2020

In a press release on the program, CTA President and CEO Gary Shapiro noted that, “The response to COVID-19 in the U.S. has highlighted the huge demand for health technology solutions. CTA’s new Public Health Technology Initiative promises to be an important, impactful effort as a public-private partnership.

Public Health 116

Public Health COVID-19 Telemedicine FDA 116